STOCKS TELEGRAPH

Category: Featured

  • Check-Cap Ltd. (CHEK) Stock Plunging Deep in Early Trading as it Announces Registered Direct Offering.

    Check-Cap Ltd. (CHEK) is a late-clinical stage company redefining the screening of colorectal cancer via the introduction of C-Scan. It is the pioneer screening test for the detection of polyps long before they transform into CRC. Its capsule-based screening technology significantly increases screening devotion globally. C-Scan uses an X-ray capsule of ultra-low-dose along with exclusive software for the generation of a 3D map of the internal colon lining.

    The price of CHEK stock during the early trading on March 1, 2022, was last checked to be $0.41 with a fall of 32.58%.

    CHEK: Events and Happenings

    On March 1, 2022, CHEK reported its entry into definitive contracts with several investors for the acquisition and sale of 20,000,000 of its ordinary shares and warrants to acquire up to 15,000,000 ordinary shares. Each ordinary share and warrant are sold to acquire 0.75 ordinary shares at a joint offering price of $0.50 per share and warrant. The offering is anticipated to close on March 3, 2022.

    On February 7, 2022, CHEK updated on the approval receipt for its altered IDE application by the FDA. The approval enabled the company to start the pivotal study. On December 23, 2021, CHEK was informed about the receipt of notification from the NASDAQ regarding non-compliance with the least bid price obligation for the continued listing to retain a least per share price of $1.00.

    On November 22, 2021, CHEK announced the publication of its research in the peer-reviewed Digestive Diseases and Sciences journal. The title of the research is ‘Colorectal cancer and polyp detection using a new preparation-free colon-scan capsule: A pilot study of safety and patient satisfaction.’

    CHEK: Key Financials

    On November 3, 2021, CHEK released its financial results for the third quarter of 2021 ended September 30, 2021. Some of the main highlights are discussed below.

    Revenue

    No revenue was recorded in the third quarter of 2021 like in the same quarter of 2020.

    EPS

    Basic and diluted net loss per share in Q3 2021 was $4.2 million or $0.15 against $3.6 million or $0.40 in the same quarter in 2020. The company observed a rise in its EPS over the year. The company also topped the EPS estimates by $0.01.

    Conclusion

    CHEK stock is approximately 20% up the last year which showed the devotedness of its team in the pandemic. In Tuesday’s early trading session, the company’s stock sank as a consequence of a registered direct offering announcement. For the fourth quarter of 2021, the company expects an EPS of -$0.04.

  • 51job Inc Stock Rose 10% Today. How Did That Happen?

    51job Inc (JOBS) shares have gained 10.66% at $57.32 in Tuesday’s early session. JOBS stock added 1.27% to finish the previous trading session at $51.80. The stock recorded a trading volume of 0.13 million shares, which is below the average daily trading volume published for the last 50 days of 0.37 million shares.

    The shares of 51job Inc. have stabilized in the last five days; however, they have gained 3.93% over the last month. The stock price has shed -4.41% over the last three months and has gained 5.87 percent so far this year. Further, the stock is being traded at a price-to-earnings ratio of 35.65. JOBS stock is surging after a merger move.

    How JOBS has been merging?

    Established in 1998, 51job Inc is the main supplier of incorporated human asset administrations in China. With an exhaustive set-up of HR arrangements, JOBS addresses the issues of ventures and occupation searchers through the whole ability of the executive’s cycle, from starting enlistment to worker maintenance and vocation advancement. JOBS likewise gives various other worth-added HR administrations, including business process re-appropriating, preparing, proficient appraisal, grounds enlistment, chief hunt, and remuneration examination.

    51job Inc (JOBS) reported today that it has gone into a revision to its recently declared Agreement and Plan of Merger dated as of June 21, 2021 (the “First Merger Agreement,” and the Original Merger Agreement as so changed, the “Altered Merger Agreement”) with Garnet Faith Limited, an excluded organization with restricted obligation consolidated under the law of the Cayman Islands (“Merger Sub”).

    As per the Amended Merger Agreement, and dependent upon the agreements thereof, Merger Sub will converge with and into JOBS with the Company being the enduring organization (the “Consolidation”). The consolidation exchange infers a value worth of JOBS of around US$4.3 billion in which the Company will be gained by a consortium of financial backers (the “Consortium”). The change follows the Company’s receipt of a letter dated January 12, 2022 (the “Reexamined Proposal”) from Merger Sub proposing to diminish the consolidation thought under the Original Merger Agreement, which was reported by the Company on January 12, 2022.

    How JOBS will be benefited?

    The Amended Merger Consideration addresses a premium of 33.10% to the end cost of the 51job Inc (JOBS) ADSs on January 11, 2022, the last exchanging day preceding the Company’s declaration of its receipt of the Revised Proposal. It is likewise along with some hidden costs of 31.38% to the volume-weighted normal shutting cost of JOBS ADSs during the most recent 30 days preceding its receipt of the Revised Proposal.

  • Sea Limited (SE) declined in the current market; here is why?

    Sea Limited (SE) declined in the current market after announcing its fourth quarter and fiscal 2021 results. SE values at $134.33, losing more than 7.73% compared to yesterday’s closing price. The stock closed at $145.60 at the end of the last trading session. The stock volume traded in the previous trading session was around 11.03 million shares. The current market cap of the company is about $81.21 billion.

    SE: Q4 and Fiscal 2021 Key Financials

    • Sea Limited’s revenue in Q4 2021 was $3.2 billion. It is an increase of more than 105% compared to the revenue of $1.5 billion in Q4 2020.
    • Fiscal 2021 revenue was $9.9 billion, 1275 more than the revenue of $4.3 billion in fiscal 2020.
    • The company’s net loss in Q4 2021 was around $616 million, 17.5% more than compared to the net loss of $524 million in Q4 2020.
    • SE net loss in fiscal 2021 was around $1.5 billion, 25.8% more than compared to the net loss of $1.3 billion in fiscal 2020.
    • The Q4 2021 loss per share was $0.88, compared to a net loss of $0.87 of Q4 2020.
    • For fiscal 2021, the loss per share was $2.96, compared to $2.78 in fiscal 2020.

    SE 2022 Guidance

    We now project digital entertainment bookings to reach between US$2.9 billion and US$3.1 billion in 2022. Following the fourth quarter and into this year, we have seen a slowdown in online activity and swings in user engagement.

    Also, owing to unexpected government measures, Free Fire is presently inaccessible in India on Google Play and iOS. The advice considers these headwinds. While we estimate reservations for 2022 to be comparable to those for 2020, we have factored in the uncertainty in India.

    The company expects e-commerce revenue to be between $8.9 and $9.1 billion. The midpoint is a 75.7% increase from 2021. SE expects digital financial services revenue to be between US$1.1 and US$1.3 billion. The midpoint indicates a 155.4 percent increase from 2021.

    Conclusion

    The company is expecting to resolve the issue of Free Fire in India as they have a significant chunk of market share there. The uncertain situation of the current ban on Free Fire in India will affect the upcoming quarters.

  • Is Meiwu Technology (WNW) Stock Price Down Today?

    At last check in current market trading, shares of Meiwu Technology Company Limited (WNW) were down 1.75% at $1.40. Meiwu Technology (WNW) stock closed the last session at $1.43, decreasing -17.82% or -$0.31. Shares of the company fluctuated between $1.40 and $2.67 throughout the day. The number of shares exchanged was 11.57 million, greater than the company’s 50-day daily volume of 0.69 million and higher than its Year to date volume of 0.78 million.

    In the past 12 months, Meiwu Technology (WNW) stock has retreated -88.72%, and in the last one week, the stock has moved down -17.82%. For the last six months, the stock has lost a total of -72.23%, and over the last three months, the stock has decreased by -54.17%. The stock has returned -39.41% so far this year. WNW stock is falling following a strategic move.

    What move does Meiwu Technology have made?

    Meiwu Technology (WNW) is a British Virgin Islands organization fused on December 4, 2018. WNW conducts business in China through its auxiliaries and variable interest element, Wunong Technology (Shenzhen) Co., Ltd. As of now WNW directs its business through a web-based retail location on the site www.wnw108.com. Enhancing the Website and ongoing information, WNW can answer to and coordinate inventory with interest for food items with regards to shopper patterns.

    Meiwu Technology (WNW) reported that in January 2022, it has formally gone into the offline experience store market. Meiwu Technology likewise plans to finish it’s on the web and disconnected shut circle retail environment under the sharing method of the front-end social sharing and participation framework and the back-end direct buy and direct stockpile.

    • In January 2022, during a 9-day yearly advancement, how many deals of WNW arrived at 1.5 times that of a similar advancement period last year, and how much the request multiplied.
    • The strengthening of disconnected experience stores is irreplaceable for acknowledging such accomplishments.
    • The yearly advancement of Meiwu Technology in the beyond two years has turned into an on the web and disconnected joint advancement.
    • During the advancement time frame this year, in excess of 50 experience stores took an interest and WNW gave in excess of 1,000 sorts of merchandise in excess of 10 urban communities the nation over with the solid help of 0.6 million enrolled individuals.

    What does WNW expect further?

    In the following two years, Meiwu Technology (WNW) hopes to foster more than 300 disconnected experience stores and hopes to build the working income by 200% and the benefit by 100 percent. WNW is performing admirably in the experience store with a strong mentality and taking extraordinary steps to invite Meiwu Technology later on.

  • Is There Any Reason As To Why The Bitfarms (BITF) Stock Expanded By 4.16% Today?

    Shares of the global Bitcoin self-mining company, Bitfarms Ltd. (BITF) were rising 4.16% to trade at $5.01 in the current market at last check. Bitfarms (BITF) stock gained 14.59% to close Monday’s session at $3.77. The stock volume remained 10.27 million shares, which was higher than the average daily volume of 7.22 million shares within the past 50 days.

    BITF shares have fallen by -27.22% over the last 12 months, and they have moved up by 9.28% in the past week. Over the past three months, the stock has lost -47.20%, while over the past six months, it has shed -36.42%. Further, the company has a current market of $993.02 million and its outstanding shares stood at 187.22 million. BITF stock is rising after sharing an update.

    Which update does BITF have shared?

    Established in 2017, Bitfarms (BITF) is a worldwide Bitcoin self-mining organization, running upward incorporated mining activities with an on-location specialized fix, exclusive information examination, and Company-claimed electrical designing and establishment administrations to convey high functional execution and uptime.

    Bitfarms (BITF) gave a Bitcoin (BTC) creation and digging activities update for February 2022.

    Mining Production

    • Bitfarms detailed a 2.3 EH/s on the web.
    • The organization announced 298 new BTC mined during February 2022, up 67% from February 2021.
    • BITF mined 10.6 BTC every day on normal in February, comparable to with regards to US$455,800 each day and adding up to roughly US$12.8 million for the month in view of a BTC cost of US$43,000 on February 28, 2022.
    • In February, BITF kept 283 BTC from mining into authority.
    • BITF have 4,883 BTC in authority on February 28, 2022, addressing a complete worth of roughly US$210 million in view of a BTC cost of US$43,000.

    Mining Operations

    During the month, Bitfarms has either gotten 7,400 new Bitcoin diggers equipped for 740 PH or is on the way. The Chinese New Year, which ran from January 31 through February 15, 2022, eased back excavator creation and conveyances; consequently, the majority of the February shipments happened in the last 50% of the month.

    At present finishing the initial 12 MW limit at The Bunker webpage in Sherbrooke, which will promptly make functional more than 3,000 new excavators and add north of 300 PH/s to BITF’s online hashrate.

    How remained the BITF?

    Approaching the launch of its two new ranches in Sherbrooke, Québec, Bitfarms (BITF) stayed on target to accomplish its objective of 3 exahash each second (EH/s) before the finish of the main quarter 2022. Digger conveyances sped up in the final part of February situating BITF to rapidly incline creation at these Sherbrooke areas.

  • Target Corp. (TGT) Stock Jumps Sharply Following the Financials Release

    Target Corp. (TGT) is based in Minneapolis and serves the clients at approximately 2,000 stores and online. The purpose of the company is to help the families discover the joy of routine life. It was established in 1946 and has given 5% of its profit to under-served communities.

    The price of TGT stock during the regular trading on February 28, 2022, was $199.7 with an increase of 0.28%. At last check in the current market on March 1, 2022, the stock took a leap by 11.38% to $222.50.

    TGT: Key Financials

    On March 1, 2022, TGT released its unaudited financial outcomes for the fourth fiscal quarter of 2021 ended January 29, 2022. Some of the key highlights are discussed below.

    Revenue

    Total revenue in Q4 2021 was $30.9 billion against $28.3 billion in the same quarter the prior year. The company reported an increase of $2.6 billion in its quarterly revenue over the year. Also, it missed the analysts’ estimates of $31.38 billion in revenue.

    EPS

    Diluted net income in Q4 2021 was $1.54 billion or $3.21 per share versus $1.38 billion or $2.73 per share for the same period in 2020. The company observed a rise in its net income over the year. The company topped the EPS estimates of $2.80.

    TGT: CEO Comments

    Speaking at the occasion, TGT CEO Brian Cornell stated that the company’s strong Q4 performance topped off 2021 as the year of record growth, strengthening its business model durability and profitable growth confidence. He further added that the company will keep investing and delivering the best services to its clients.

    TGT: Events and Happenings

    On February 28, 2022, TGT reported about its plans to set a new early wage range and increase the health care benefits access for its employees and their families. Therefore, the company is on its way to achieving another milestone in its long-standing commitment to its team members.

    On February 23, 2022, TGT updated on its plans to continue improving its same-day pickup services in the winters of 2022. The company will begin checking the option for clients in chosen localities to add a Starbucks order or make a return within the company’s contactless curbside platform via its app.

    Conclusion

    TGT stock outperformed by 7% in the past year. The recent stock swell is due to its financial statement release as it topped the EPS estimates but missed the revenue target.

  • Powerbridge Technologies (PBTS) Positioned to Capture Quick Gains

    Late into the pre-market of the trading, the stock of Powerbridge Technologies (PBTS) continues to turn heads, seeing a persistent climb of up to 4.33% observed at a certain point in time. This low-priced stock, although still well beneath the $1 mark, has been in a steady bearish movement since its stock began trading in 2019. The recent turn in events put the stock as one seeing steady growth over the previous day which happens to coincide with the bullish trend of Bitcoin observed across the last five days.

    PBTS Background and Prospects

    PBTS, the China-based software company which specializes in blockchain technologies, and is involved in the mining of various cryptocurrencies, has been on the news late last year. This had been in relation to the announcement of its wholly-owned subsidiary of Powerstream Supply Chain Limited, looking to implement SaaS solutions in the global supply chain domain. Earlier in February, the company further announced its ambitions to venture into virtual technologies, amidst popular discourse on metaverse related technologies, and their implications. In order to actualize these ambitions, the company announced the launch of Metafusion Company Limited, in a joint partnership with its subsidiary, Powermeta Digital Company. Despite the promise of these breakthroughs, there had been little impact on the stock price of the company in the periods following these announcements.

    Discourse across Social Media

    Chatter amongst investors across various social media platforms indicates that the PBTS stock is being closely assessed with anticipation of high short-term growth. This is being expected to be similar to that which had been observed with the MULN stock, last night, which saw a phenomenal 263% growth in a five-day period, being dubbed a “short squeeze”. Users on both Reddit and Twitter have been linking the rapid growth in the after-trading hours of the stock with Bitcoin gains, which Powerbridge had capitalized on through its crypto-mining activity.

    Conclusion

    Traders eyeing the stock believe it is currently at a turning point and will continue to see significant growth well into the pre-market trading hours into the next few days. An announcement from the company is awaited, announcing its successful gains from Bitcoin and Ethereum mining, which would only enhance confidence across the market. However, the degree to which these optimistic expectations will actually be met remains ambiguous, primarily due to the low price of the stock, still well below the $1 mark.

  • CTI BioPharma Corp. (CTIC) Stock Rebounds Premarket Following FDA Accelerated Approval.

    CTI BioPharma Corp. (CTIC) a commercial-stage biotherapeutics company engaged in the purchase, manufacture, and marketing of innovative targeted therapeutics for blood cancer. The company’s one of the FDA-approved product is VONJO or pacritinib, used in treating intermediate or high-risk primary or secondary myelofibrosis. The company is also conducting Phase 3 PACIFICA trials for VONJO in patients with severe thrombocytopenia.

    The price of CTIC stock during the regular trading on February 28, 2022, was $1.9 with a decrease of 19.8%. At last check in the premarket on March 1, 2022, the stock rocketed by 53.68%.

    CTIC: Events and Happenings

    On February 28, 2022, CTIC reported the approval of VONJO by the FDA for treating myelofibrosis. It is the primary approved therapy that precisely addresses the requirements of patients with this condition. On February 18, 2022, CTIC updated that its Board of Directors had granted an equity inducement award to the company’s employees. The award was approved on February 16, following the Nasdaq Listing Rules.

    On December 13, 2021, CTIC announced its lead candidate’s poster presentations at the Virtual Annual Meeting & Exposition of 63rd American Society of Hematology held on December 11-14, 2021. On December 2, 2021, CTIC updated its management’s presentation at the Virtual JMP Securities Hematology & Oncology Summit on December 6, 2021.

    CTIC: Key Financials

    On July 29, 2021, CTIC released its financial statement for the second fiscal quarter of 2021 ended June 30, 2021. Some of the key features are discussed below.

    Revenue

    No revenue was recorded in Q2 2021 and the same quarter of 2020.

    EPS

    Basic and diluted net loss in Q2 2021 was $19.6 million or $0.21 per share compared to $14 million or $0.19 per share for the same quarter in 2020. The company observed an increase in its net loss over the year.

    Conclusion

    CTIC stock is at a new low for the past six months as it dipped by 42% due to the pandemic. The recent premarket stock leap is the result of the groundbreaking approval of its lead candidate by the FDA. The company is gearing for its earnings release date and expecting an EPS of -$0.30.

  • Legend Biotech Corp. (LEGN) Stock Soaring Premarket Following FDA Approval of its Product.

    Legend Biotech Corp. (LEGN) is an international, clinical-stage company focused on the treatment of life-threatening diseases. It develops a unique array of technology portfolios, including TCR-T, and NK cell-based immunotherapy. The lead candidate of the company is ciltacabtagene autoleucel, CAR-T cell therapy for treating multiple myeloma.

    The price of LEGN stock during the regular trading on February 28, 2022, was $39.5 with a gain of 3.05%. At last check in the premarket on March 1, 2022, the stock escalated by 8.06%.

    LEGN: Events and Happenings

    On March 1, 2022, LEGN reported the approval of its preliminary product CARVYKTI or cilta-cel by the FDA.  It will now be used in the treatment of patients with relapsed or refractory multiple myeloma. The company had already entered into a global licensing and collaboration contract with Janssen Biotech, for the development and commercialization of cilta-cel.

    On February 18, 2022, LEGN updated the preliminary financial outcomes for the fiscal year ended December 31, 2021. The company’s net loss of the period will be $365.3 million to $397.4 million. On February 15, 2022, LEGN announced that FDA had put a clinical hold on the company’s Phase 1 clinical trial for LB1901. It is used for the treatment of patients with relapsed or refractory T-cell lymphoma.

    On January 4, 2022, LEGN informed that its Executive management presented at the Virtual 40th Annual J.P. Morgan Healthcare Conference held on January 11, 2022. ON December 16, 2021, LEGN reported the pricing of an underwritten public offering of 7,500,000 ADS, at a public offering price of $40.00 per ADS. The total gross proceeds from the offering were expected to be approximately $300.0 million.

    LEGN: Key Financials

    On November 16, 2021, LEGN released its quarterly financial statement for the third quarter of 2021 ended September 30, 2021. Some of the key observations are discussed below.

    Revenue

    Revenue in Q3 2021 was $16.9 million as opposed to $11.7 million in the same quarter in 2020. The company observed an improvement of $5.2 million in its revenue over the year. The company topped the analysts’ expectations by $9.05 million.

    EPS

    Basic and diluted net loss in Q3 2021 was $124.8 million or $0.43 per share contrary to $66.5 million or $0.25 per share in the same period of 2020. The company observed a decline in its EPS over the year. Also, the company missed the EPS estimates of the analysts by -$0.08.

    Conclusion

    LEGN stock outperformed in the past few months as the company recorded a 49% gain in its stock price for the period. The company’s recent statement is the factor that impacted its premarket stock position. The company reported groundbreaking news of the approval of CARVYKTI by the FDA and in return, its stock escalated. The earnings release date is also advancing and the company expects revenue of $14.2 million against EPS of -$0.44.

  • DSS Inc (DSS) stock lost 6.54% in the pre-market. Here’s why

    The stock of DSS Inc (DSS) closed the recent trading session at $0.56, gaining 47.24% from the previous trading session. On the last check, the stock lost 6.54% in the pre-market, to $0.53. DSS Inc issued a letter to its investors on February 28, 2022.

    DSS is a global organization working in blockchain security, marketing, medical care, land, banking, loaning, and finance. Its plan of action depends on a circulation framework in which investors get the shares in its auxiliaries. With a market cap of $45.14 million, the company has 79.75 million shares pending. The headquarter of DSS is in Victor, New York, United States of America (USA).

    DSS News

    On 28 February 2022, DSS issued a letter to its investors. The letter states that the energetic work of their devoted team has prompted critical value creation and has put them in a strong direction for sped-up development. The company said that in only two years, they added eight business lines. They also developed resources for more than $219 million, including $69 million for cash. Through three fruitful public offerings, the company raised total returns of more than $121 million.

    One of DSS’s subsidiaries, American Pacific Bancorp Inc (ABP) lent almost $26 million since September 2021 and has gathered a broadened arrangement of solid credit quality. APB’s portfolio incorporates legislative securities, C&I stock, and land advancement credits. DSS invested $40 million in ABP during the Q3 of FY21, which has been very fruitful. This investment drove the advancement of their business pay model in a greater number of ways.

    DSS also declared that Impact BioMedical, the foundation of their bio-health group, advanced on various fronts in 2021. They expect to report the first license deal soon. The direct selling of the company expanded by $170 million with high benefits due to the shift to in-home shopping and the development of the gig economy.

    The CEO of DSS, Frank D. Heuszel, commented that simulated by advancement, industry needs, and acquisitions, they are centered around and prepared to enable the brands. He further added that they remain dedicated to wealth creation and accept that they have established an essential framework for future growth.